Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas.
Martianov AS, Mitiushkina NV, Ershova AN, Martynenko DE, Bubnov MG, Amankwah P, Yanus GA, Aleksakhina SN, Tiurin VI, Venina AR, Anuskina AA, Gorgul YA, Shestakova AD, Maidin MA, Belyaev AM, Baboshkina LS, Iyevleva AG, Imyanitov EN. Martianov AS, et al. Among authors: aleksakhina sn. Int J Mol Sci. 2023 Mar 2;24(5):4868. doi: 10.3390/ijms24054868. Int J Mol Sci. 2023. PMID: 36902296 Free PMC article.
Evidence for angiogenesis-independent contribution of VEGFR1 (FLT1) in gastric cancer recurrence.
Suspitsin EN, Kashyap A, Shelekhova KV, Sokolenko AP, Kuligina ESh, Iyevleva AG, Kornilov AV, Ehemann V, Yanus GA, Aleksakhina SN, Preobrazhenskaya EV, Zaitseva OA, Yatsuk OS, Klimashevsky VF, Togo AV, Imyanitov EN. Suspitsin EN, et al. Among authors: aleksakhina sn. Med Oncol. 2013;30(3):644. doi: 10.1007/s12032-013-0644-2. Epub 2013 Jun 26. Med Oncol. 2013. PMID: 23801279
Pattern of clinically relevant mutations in consecutive series of Russian colorectal cancer patients.
Yanus GA, Belyaeva AV, Ivantsov AO, Kuligina ESh, Suspitsin EN, Mitiushkina NV, Aleksakhina SN, Iyevleva AG, Zaitseva OA, Yatsuk OS, Gorodnova TV, Strelkova TN, Efremova SA, Lepenchuk AY, Ochir-Garyaev AN, Paneyah MB, Matsko DE, Togo AV, Imyanitov EN. Yanus GA, et al. Among authors: aleksakhina sn. Med Oncol. 2013;30(3):686. doi: 10.1007/s12032-013-0686-5. Epub 2013 Aug 14. Med Oncol. 2013. PMID: 23943423
High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients.
Sokolenko AP, Bulanova DR, Iyevleva AG, Aleksakhina SN, Preobrazhenskaya EV, Ivantsov AO, Kuligina ESh, Mitiushkina NV, Suspitsin EN, Yanus GA, Zaitseva OA, Yatsuk OS, Togo AV, Kota P, Dixon JM, Larionov AA, Kuznetsov SG, Imyanitov EN. Sokolenko AP, et al. Among authors: aleksakhina sn. Int J Cancer. 2014 May 15;134(10):2352-8. doi: 10.1002/ijc.28569. Epub 2014 Jan 27. Int J Cancer. 2014. PMID: 24470238 Free article.
Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations.
Sokolenko AP, Bogdanova N, Kluzniak W, Preobrazhenskaya EV, Kuligina ES, Iyevleva AG, Aleksakhina SN, Mitiushkina NV, Gorodnova TV, Bessonov AA, Togo AV, Lubiński J, Cybulski C, Jakubowska A, Dörk T, Imyanitov EN. Sokolenko AP, et al. Among authors: aleksakhina sn. Breast Cancer Res Treat. 2014 Jun;145(2):553-62. doi: 10.1007/s10549-014-2971-1. Epub 2014 May 7. Breast Cancer Res Treat. 2014. PMID: 24800916
Novel ALK fusion partners in lung cancer.
Iyevleva AG, Raskin GA, Tiurin VI, Sokolenko AP, Mitiushkina NV, Aleksakhina SN, Garifullina AR, Strelkova TN, Merkulov VO, Ivantsov AO, Kuligina ESh, Pozharisski KM, Togo AV, Imyanitov EN. Iyevleva AG, et al. Among authors: aleksakhina sn. Cancer Lett. 2015 Jun 28;362(1):116-21. doi: 10.1016/j.canlet.2015.03.028. Epub 2015 Mar 23. Cancer Lett. 2015. PMID: 25813404
BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment.
Protsenko SA, Semionova AI, Komarov YI, Aleksakhina SN, Ivantsov AO, Iyevleva AG, Imyanitov EN. Protsenko SA, et al. Among authors: aleksakhina sn. Invest New Drugs. 2015 Oct;33(5):1136-43. doi: 10.1007/s10637-015-0280-0. Epub 2015 Aug 20. Invest New Drugs. 2015. PMID: 26286452
37 results